218 related articles for article (PubMed ID: 7443111)
1. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
Hartikainen-Sorri AL; Kauppila A; Tuimala R
Obstet Gynecol; 1980 Dec; 56(6):692-5. PubMed ID: 7443111
[TBL] [Abstract][Full Text] [Related]
2. High-risk prematurity--progestin treatment and steroid studies.
Johnson JW; Lee PA; Zachary AS; Calhoun S; Migeon CJ
Obstet Gynecol; 1979 Oct; 54(4):412-8. PubMed ID: 492618
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.
Awwad J; Usta IM; Ghazeeri G; Yacoub N; Succar J; Hayek S; Saasouh W; Nassar AH
BJOG; 2015 Jan; 122(1):71-9. PubMed ID: 25163819
[TBL] [Abstract][Full Text] [Related]
4. Does 17-α-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?
Mulder EJ; Versteegh EM; Bloemenkamp KW; Lim AC; Mol BW; Bekedam DJ; Kwee A; Bruinse HW; Christiaens GC
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):329-34. PubMed ID: 23592400
[TBL] [Abstract][Full Text] [Related]
5. Does progesterone treatment influence risk factors for recurrent preterm delivery?
Meis PJ; Klebanoff M; Dombrowski MP; Sibai BM; Leindecker S; Moawad AH; Northen A; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Miodovnik M; Leveno KJ; Conway D; Wapner RJ; Carpenter M; Mercer B; Ramin SM; Thorp JM; Peaceman AM; Gabbe S
Obstet Gynecol; 2005 Sep; 106(3):557-61. PubMed ID: 16135587
[TBL] [Abstract][Full Text] [Related]
6. 17 hydroxyprogesterone for the prevention of preterm delivery.
Meis PJ;
Obstet Gynecol; 2005 May; 105(5 Pt 1):1128-35. PubMed ID: 15863556
[TBL] [Abstract][Full Text] [Related]
7. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
[TBL] [Abstract][Full Text] [Related]
8. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.
Spong CY; Meis PJ; Thom EA; Sibai B; Dombrowski MP; Moawad AH; Hauth JC; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Miodovnik M; Leveno KJ; Conway D; Wapner RJ; Carpenter M; Mercer B; Ramin SM; Thorp JM; Peaceman AM; Gabbe S;
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1127-31. PubMed ID: 16157124
[TBL] [Abstract][Full Text] [Related]
9. 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial.
Combs CA; Garite T; Maurel K; Das A; Porto M;
Am J Obstet Gynecol; 2011 Mar; 204(3):221.e1-8. PubMed ID: 21376161
[TBL] [Abstract][Full Text] [Related]
10. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.
Rouse DJ; Caritis SN; Peaceman AM; Sciscione A; Thom EA; Spong CY; Varner M; Malone F; Iams JD; Mercer BM; Thorp J; Sorokin Y; Carpenter M; Lo J; Ramin S; Harper M; Anderson G;
N Engl J Med; 2007 Aug; 357(5):454-61. PubMed ID: 17671253
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
Facchinetti F; Vaccaro V
Minerva Ginecol; 2009 Oct; 61(5):401-9. PubMed ID: 19749671
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
Saghafi N; Khadem N; Mohajeri T; Shakeri MT
J Obstet Gynaecol Res; 2011 Oct; 37(10):1342-5. PubMed ID: 21564406
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
How HY; Barton JR; Istwan NB; Rhea DJ; Stanziano GJ
Am J Obstet Gynecol; 2007 Sep; 197(3):260.e1-4. PubMed ID: 17826411
[TBL] [Abstract][Full Text] [Related]
14. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine.
Kauppila A; Hartikainen-Sorri AL; Jänne O; Tuimala R; Järvinen PA
Am J Obstet Gynecol; 1980 Oct; 138(4):404-8. PubMed ID: 7424996
[TBL] [Abstract][Full Text] [Related]
15. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
Odibo AO; Stamilio DM; Macones GA; Polsky D
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):492-9. PubMed ID: 16946206
[TBL] [Abstract][Full Text] [Related]
16. The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies.
Gyamfi C; Horton AL; Momirova V; Rouse DJ; Caritis SN; Peaceman AM; Sciscione A; Meis PJ; Spong CY; Dombrowski M; Sibai B; Varner MW; Iams JD; Mercer BM; Carpenter MW; Lo J; Ramin SM; O'Sullivan MJ; Miodovnik M; Conway D;
Am J Obstet Gynecol; 2009 Oct; 201(4):392.e1-5. PubMed ID: 19716543
[TBL] [Abstract][Full Text] [Related]
17. The origin and outcome of preterm twin pregnancies.
Gardner MO; Goldenberg RL; Cliver SP; Tucker JM; Nelson KG; Copper RL
Obstet Gynecol; 1995 Apr; 85(4):553-7. PubMed ID: 7898832
[TBL] [Abstract][Full Text] [Related]
18. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate.
Yemini M; Borenstein R; Dreazen E; Apelman Z; Mogilner BM; Kessler I; Lancet M
Am J Obstet Gynecol; 1985 Mar; 151(5):574-7. PubMed ID: 3976757
[TBL] [Abstract][Full Text] [Related]
19. Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial.
Lim AC; Bloemenkamp KW; Boer K; Duvekot JJ; Erwich JJ; Hasaart TH; Hummel P; Mol BW; Offermans JP; van Oirschot CM; Santema JG; Scheepers HC; Schöls WA; Vandenbussche FP; Wouters MG; Bruinse HW;
BMC Pregnancy Childbirth; 2007 Jun; 7():7. PubMed ID: 17578562
[TBL] [Abstract][Full Text] [Related]
20. 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.
Lim AC; Schuit E; Bloemenkamp K; Bernardus RE; Duvekot JJ; Erwich JJHM; van Eyck J; Groenwold RHH; Hasaart THM; Hummel P; Kars MM; Kwee A; van Oirschot CM; van Pampus MG; Papatsonis D; Porath MM; Spaanderman ME; Willekes C; Wilpshaar J; Mol BWJ; Bruinse HW
Obstet Gynecol; 2011 Sep; 118(3):513-520. PubMed ID: 21860279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]